Reports and Briefs on Pharmaceuticals and Healthcare in Japan

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

The Hepatitis C Market Outlook to 2022

The hepatitis C market will experience a boom as revolutionary interferon-free regimens arrive.

Published By Datamonitor
17 Apr 2013 $2800
Buy
Report
Report

The Inflammatory Bowel Disease Market Outlook to 2021

The IBD market is set to experience considerable change over the next ten years. A number of significant new product launches will reshape the market, with sales for ulcerative colitis forecast to overtake those for Crohn's disease.

Published By Datamonitor
22 Mar 2013 $2800
Buy
Report
Report

The Dyslipidemia Market Outlook to 2021

In the wake of Lipitor’s patent expiry, the dyslipidemia market continues to face increasing genericization leading to falling sales in key drug classes.

Published By Datamonitor
04 Feb 2013 $2800
Buy
Report
Report

The Osteoporosis Market Outlook to 2021

New anti-bone loss drugs soon to reach the osteoporosis market - but generic entry will continue to erode its value.

Published By Datamonitor
17 Jan 2013 $2800
Buy
Report
Report

Pipeline: Renal Cell Cancer

Renal cell cancer continues to attract drug developers in spite of the crowded nature of the market.

Published By Datamonitor
15 Jan 2013 $2800
Buy
Report
Report

The Orphan Drug Market Outlook to 2017

This report provides an analysis of the orphan drug market. It comprises brands that have gained US FDA orphan drug approval, as well as Phase III pipeline candidates that have gained an orphan drug designation from the FDA.

Published By Datamonitor
08 Jan 2013 $2800
Buy
Report
Report

Forecast: Pneumococcal Vaccines

This report forecasts the pneumococcal vaccine market in the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK). It segments the market by brand and population groups, considering future changes to national recommendations.

Published By Datamonitor
05 Dec 2012 $6400
Buy
Report
Report

Treatment Algorithms: Postherpetic Neuralgia – Lyrica forms the cornerstone of treatment for postherpetic neuralgia

Analysis of the treatment dynamics in postherpetic neuralgia (PHN). Contains analyses of presentation, diagnosis and treatment rates, and prescribing trends across the seven major markets using Datamonitor’s primary research of 131 physicians.

Published By Datamonitor
13 Nov 2012 $4800
Buy
Report
Report

Non-Small Cell Lung Cancer in China – High smoking prevalence and environmental exposures will continue to drive lung cancer incidence

Overview of non-small cell lung cancer definition and a review of the epidemiologic literature. This report provides an in-depth analysis of patient populations, a 10-year incident forecast, and key patient segments in China.

Published By Datamonitor
31 Oct 2012 $2800
Buy
Report
Report

Market and Product Forecasts: Alzheimer's Disease – Multi-billion dollar potential in high-risk pipeline

Datamonitor uses a patient-based approach to size the commercial potential of Alzheimer’s disease across the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK) from 2011 to 2021.

Published By Datamonitor
25 Oct 2012 $6400
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.